An effective vaccine is only the first step: the need to create and sustain demand for TB vaccines
- PMID: 37749838
- PMCID: PMC10519388
- DOI: 10.5588/ijtld.23.0365
An effective vaccine is only the first step: the need to create and sustain demand for TB vaccines
Conflict of interest statement
Conflicts of interest: none declared.
References
-
- Treatment Action Group 2022 pipeline report. New York, NY, USA: TAG; 2022.
-
- Tait DR, et al. Final analysis of a trial of M72/AS01E vaccine to prevent tuberculosis. N Engl J Med. 2019;381(25):2429–2439. - PubMed
-
- Tameris M, et al. Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial. Lancet Respir Med. 2019;7(9):757–770. - PubMed
-
- MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34):4161–4164. - PubMed
-
- World Health Organization Evidence considerations for vaccine policy development (ECVP) Geneva, Switzerland: WHO; 2022.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
